Skip to main content
Premium Trial:

Request an Annual Quote

Kerry Flom, Waun Ki Hong, Jay Tischfield, David Alberts, Michael Hogan

Premium

Kerry Flom has joined Cepheid as vice president of clinical affairs, the company announced on June 30. Most recently, he directed the clinical and regulatory submissions group at Abbott Molecular Diagnostics. Prior to that, he directed the clinical affairs departments at Vysis. Flom holds a PhD in biochemistry from the University of Illinois at Urbana-Champaign.


Waun Ki Hong of the MD Anderson Cancer Center at the University of Texas, Jay Tischfield of the Rutgers University Department of Genetics, and David Alberts of the Arizona Cancer Center at the University of Arizona join GenVault’s new scientific advisory board. Michael Hogan, chief scientific officer, will serve as director of the board, the company said this week.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.